Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration

Open access
Woodbury, Maya E., Ikezu, Tsuneya · 2014 · Journal of Neuroimmune Pharmacology

Abstract

Fibroblast growth factor-2 (FGF2), also known as basic FGF, is a multi-functional growth factor. One of the 22-member FGF family, it signals through receptor tyrosine kinases encoding FGFR1-4. FGF2 activates FGFRs in cooperation with heparin or heparin sulfate proteoglycan to induce its pleiotropic effects in different tissues and organs, which include potent angiogenic effects and important roles in the differentiation and function of the central nervous system (CNS). FGF2 is crucial to development of the CNS, which explains its importance in adult neurogenesis. During development, high levels of FGF2 are detected from neurulation onwards. Moreover, developmental expression of FGF2 and its receptors is temporally and spatially regulated, concurring with development of specific brain regions including the hippocampus and substantia nigra pars compacta. In adult neurogenesis, FGF2 has been implicated based on its expression and regulation of neural stem and progenitor cells in the neurogenic niches, the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampal dentate gyrus. FGFR1 signaling also modulates inflammatory signaling through the surface glycoprotein CD200, which regulates microglial activation. Because of its importance in adult neurogenesis and neuroinflammation, manipulation of FGF2/FGFR1 signaling has been a focus of therapeutic development for neurodegenerative disorders, such as Alzheimer's disease, multiple sclerosis, Parkinson's disease and traumatic brain injury. Novel strategies include intranasal administration of FGF2, administration of an NCAM-derived FGFR1 agonist, and chitosan-based nanoparticles for the delivery of FGF2 in pre-clinical animal models. In this review, we highlight current research towards therapeutic interventions targeting FGF2/FGFR1 in neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11481-013-9501-5

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Cited by

See all 295

Metadata

Authors
Woodbury, M. E., & Ikezu, T.
Affiliations
Boston University (US)
Corresponding author
Ikezu, Tsuneya
Venue
Journal of Neuroimmune Pharmacology
Published
2013-09-21
Volume
9
Issue
2
Pages
92-101
ISSN
  • 1557-1890 (ISSN-L)
  • 1557-1904
OpenAlex
W1994123191
Cited by
266
References
86
Citations by year
2026: 12 · 2025: 23 · 2024: 19 · 2023: 25 · 2022: 30 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 20 · 2017: 16 · 2016: 21 · 2015: 13 · 2014: 10
FWCI
1.57
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Neuroimmune Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (T32GM008541)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
fibroblast growth factor 2, basic FGF, FGFR1 signaling, adult neurogenesis, neurodegeneration, neuroinflammation, microglial activation, CD200, neural stem/progenitor cells, subventricular zone, subgranular zone, hippocampus, substantia nigra pars compacta, neurogenic niche, neurodegenerative disease treatment, chitosan nanoparticles, Alzheimer's disease, multiple sclerosis, Parkinson's disease, traumatic brain injury
MeSH terms
Animals, Humans, Nerve Degeneration, Signal Transduction, Fibroblast Growth Factor 2, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration. https://app.cochat.ai/papers/10.1007/s11481-013-9501-5
The paper
Woodbury, M. E., & Ikezu, T. (2014). Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-013-9501-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.